Abstract:Aim The accumulating evidence suggests that C- reactive protein (CRP) may have direct inflammatory effects on the vascular wall and that statin therapy may have important non-lipid anti-inflammatory effects confirmed by decreasing serum inflammatory markers,such as CRP. However, the effect of pravastatin,fluvastatin and simvastatin on interleukin-6 (IL-6) release in cultured human monocytes from patients with acute coronary syndrome(ACS) was not investigated. Methods Monocytes were isolated from blood of patients with ACS and healthy volunteers by the Ficoll density gradient and stimulated by CRP (20 mg·L -1)for 24 h. Also 1×10 -6,2.5×10 -6,5×10 -6,7.5×10 -6,1×10 -5 mol·L -1 pravastatin, fluvastatin and simvastatin was coincubated with cells in the presence of CRP. Measurements of IL-6 were performed from supernatants of cultured medium in duplicate, using a commercial assay kit. Results ① CRP induced the release of IL-6, with significantly elevated levels in cultured supernatants in ACS group, SAP group and healthy group compared with their negative control respectively . A greater than several fold increase of IL-6 induced by CRP was observed in ACS group than other group s. ② Pravastatin,fluvastatin and simvastatin inhibited significantly the produ ction of IL-6 in monocytes stimulated by CRP in dose-dependent manner, a greater decrease was observed in pravastatin and fluvastatin than simvastatin (P0.05 ). Conclusion CRP could induce more IL-6 release in human monocyte from patients with ACS than from healthy volunteer.This may contribute to the mechanism of coronary artery disease in addition to being an incidental product of various types of systemic inflammation. Pravastatin and fluvastatin could inhibit this response in a dose-dependent manner in ACS group better than simvastatin, which may provide a new insight into the mechanisms of anti-inflammatory or anti-atherosclerotic actions of pravastatin and fluvastatin.

Influence of intervention with simvastatin and enalapril on the levels of CRP and IL-6 in patients with acute coronary syndrome

Effects of Different Doses of Rosuvastatin on High-sensitivity C-reactive Protein(hs-CRP) and Interleukin-6 (IL-6) in Patients with Acute Coronary Syndrome.

The effect of simvastatin on C reactive protein in patients with coronary heart disease

Effect of Simvastatin Upon Serum Levels of Interleukin-6 and High-Sensitivity C-reactive Protein in Patients with Acute Coronary Syndrome

Relationship Between Serum Concentrations of IL-18, IL-10, IL-6 and Acute Coronary Syndrome

The Effect of Simvastatin and Pravastatin on Serum Lipid and C Reactive Protein in Patients with Acute Coronary Syndrome

Effects of Simvastatin on Blood Levels of Inflammatory Cytokines in Patients with Unstable Angina Post Percutaneous Coronary Intervention

Effect of Simvastatin on Serum Level of Inflammatory Factors in Acute Coronary Syndrome

Effect of Simvastatin on Acute Coronary Syndrome Complicated with Atrial Fibrillation

Influnence of Simvastatin on high-sensitivity C-reactive protein and fibrinogen concentrations in patients with unstable angina

The effect of simvastatin on serum cytokine levels in patients with acute myocardial infarction

Influence of intervention with statins on the levels of cholesterol and inflammatory markers on non-ST-elevation acute coronary syndrome patients

Clinic study on anti-inflammatory effects of atorvastatin associated with rampril in patients with acute coronary syndrome

Effect of Simvastatin on the Improvement of Cardiac Function and CRP Level of Patients with Chronic Heart Failure

Influence of Short-Term Treatment with Simvastatin 40 Mg on Plasma Concentration of High-Sensitivity C-reactive Protein in Patients with Unstable Angina Pectoris

Direct Proinflammatory Effect of C-reactive Protein on Human Monocytes Isolated from Patients with Acute Coronary Syndrome and Statins Intervention

Inflammatory Factors in the Serum of Patients with Acute Coronary Syndrome:Changes and Their Implications

The Inflammatory Factors Change in Patients with Acute Coronary Syndrome after Clinical Rosuvas-tatin Calcium Therapy

Effects of Atorvastatin on Interleukin-1 and C-reactive Protein Levels of Patients with Acute Myocardial Infarction

The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndrome.

Influence of Simvastatin for In-stent Restenosis Rate and Blood Lipid Level and Inflammation Actor after Coronary Artery Stent Implantation